Göteborg, Sweden

Anders Waas



 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Göteborg, SE (2019)
  • Gothenburg, SE (2021)

Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Anders Waas

Introduction

Anders Waas is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of medical technology, particularly in the area of angiogenesis and ischemia treatment. With a total of four patents to his name, Waas continues to push the boundaries of innovation in his field.

Latest Patents

Waas's latest patents focus on the use of dextran sulfate for medical applications. One of his patents describes the use of dextran sulfate having an average molecular weight below 10,000 Da for inducing angiogenesis in a subject and for increasing blood flow in a subject suffering from ischemia. This innovative approach has the potential to improve treatment outcomes for patients with vascular issues.

Career Highlights

Anders Waas is currently associated with Tx Medic AB, where he applies his expertise to develop cutting-edge medical solutions. His work has garnered attention for its potential to transform patient care and enhance recovery processes.

Collaborations

Waas collaborates with talented individuals in his field, including Lars M Bruce and Adam Bruce. These partnerships contribute to the innovative environment at Tx Medic AB, fostering the development of new ideas and technologies.

Conclusion

Anders Waas exemplifies the spirit of innovation in the medical field through his patents and collaborative efforts. His work on dextran sulfate has the potential to significantly impact the treatment of ischemia and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…